Relation’s piece previews a biotech profile about building causal, perturbation‑driven AI platforms that tightly couple computational models with lab experiments. It invites readers curious about how interventional multi‑omic modeling could reshape therapeutic discovery.
Key Takeaways
- Artificial intelligence has become an increasingly familiar fixture in drug discovery
- Relation has unveiled MORGAN (Multi-Omic Regulatory Genomics using Artificial Neural Networks)
- Longevity.Technology: Longevity has become remarkably adept at describing aging